| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1988;46:47-57
© 1988 The Society of Thoracic Surgeons
Second Department of Surgery and the Department of Immunology, Kochi Medical School, Kochi, Japan
Accepted for publication December 30, 1987.
* Address reprint requests to Dr. Tamiya, The Second Department of Surgery, Kochi Medical School, Okoh-cho Nankoku, Kochi Prefecture, Japan 781–51
Complement activation by cardiopulmonary bypass (CPB) was studied in 82 patients divided into membrane (MOG) and bubble oxygenator groups (BOG). The influence of primed homologous to circulating autologous blood volume (H/A) ratio was also evaluated. C4a increased very slowly during CPB in both groups, maintaining slightly higher levels in the BOG than in the MOG, with the exception of a marked initial rise in the BOG with a high H/A ratio (≥20%). Anaphylatoxin C3a levels increased more steeply in the BOG than in the MOG. An obvious rise in anaphylatoxin C5a production was observed in the BOG alone. The influence of high H/A ratio perfusion on complement activation was milder in the MOG than in the BOG. In 20 monkeys (Macaca fascicularis), continuous intraaortic infusion with bubbled autologous blood increased C4a and C3a levels, while autologous blood extracorporeally contacted with nylon increased C3a levels alone. In vitro studies revealed that human immunoglobulin fractions denatured by oxygen bubbling produced C4a, C3a, and C5a in a dose-dependent manner, although human albumin treated identically as human immunoglobulin did not produce these complements. It was thus inferred that (1) during CPB, complement is predominantly activated via the classical pathway in the BOG and via the alternative pathway in the MOG; (2) higher anaphylatoxin levels in the BOG than in the MOG are related to mode and grade of blood trauma; (3) anaphylatoxin level differences in both groups tend to increase with high H/A perfusion; and (4) immunoglobulin-free sera may reduce classical pathway activation.
This article has been cited by other articles:
|
|
 |
|
  M. Kocakulak, I. C. Kocum, and H. Ayhan Investigation of inflammatory response at blood-poly (2-methoxyethyl acrylate) (PMEA) interface in vivo via scanning tunneling microscope Journal of Bioactive and Compatible Polymers, January 1, 2012; 27(1): 45 - 53. [Abstract] [PDF]
|
|
|
|
 |
|
 J. W. Hammon Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389. [Full Text]
|
|
|
|
 |
|
 R. A. Rodriguez, F. Rubens, D. Belway, and H. J. Nathan Residual air in the venous cannula increases cerebral embolization at the onset of cardiopulmonary bypass Eur J Cardiothorac Surg, February 1, 2006; 29(2): 175 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S V Sheppard, R V Gibbs, and D C Smith Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide production? Perfusion, January 1, 2004; 19(1): 7 - 10. [Abstract] [PDF]
|
|
|
|
|
|
P. Menasche and L. H. Edmunds Jr. Extracorporeal Circulation: The Inflammatory Response Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360. [Full Text]
|
|
|
|
 |
|
 J. Milot, J. Perron, Y. Lacasse, L. Letourneau, P. C. Cartier, and F. Maltais Incidence and Predictors of ARDS After Cardiac Surgery Chest, March 1, 2001; 119(3): 884 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Dreyer, S. C. Phillips, M. L. Lindsey, P. Jackson, N. E. Bowles, L. H. Michael, and M. L. Entman Interleukin 6 induction in the canine myocardium after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 256 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Watanabe, J.-i. Hayashi, H. Ohzeki, H. Moro, M. Sugawara, and S. Eguchi Biocompatibility of a silicone-coated polypropylene hollow fiber oxygenator in an in vitro model Ann. Thorac. Surg., May 1, 1999; 67(5): 1315 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I Welters, T Menges, M Ballesteros, A Sablotzki, G Gorlach, and G Hempelmann Acute phase and opsonin response in cardiac surgery patients: influence of underlying cardiac disease Perfusion, December 1, 1998; 13(6): 447 - 454. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Hussain, C. V. Murali, P. Willi, C. P. Sharma, G. S. Bhuvneshwar, and R. Sreekumar Comparative Complement Activation Study of Polypropylene Hollow Fibres of Two Different Makes in Static Condition J Biomater Appl, April 1, 1998; 12(4): 300 - 320. [Abstract] [PDF]
|
|
|
|
|
|
R de Vroege, P M. Rutten, C Kalkman, T A Out, P G. Jansen, L Eijsman, B J. de Mol, and C R. Wildevuur Biocompatibility of three different membrane oxygenators: effects on complement, neutrophil and monocyte activation Perfusion, December 1, 1997; 12(6): 369 - 375. [Abstract] [PDF]
|
|
|
|
|
|
G. Hetland, O. Moen, K. Bergh, K. Hogasen, C. E. Hack, T. E. Mollnes, and E. Fosse Both Plasma- and Leukocyte-Associated C5a Are Essential for Assessment of C5a Generation In Vivo Ann. Thorac. Surg., April 1, 1997; 63(4): 1076 - 1080. [Abstract] [Full Text]
|
|
|
|
|
|
M. Ranucci, S. Cirri, D. Conti, A. Ditta, A. Boncilli, A. Frigiola, and L. Menicanti Beneficial Effects of Duraflo II Heparin-Coated Circuits on Postperfusion Lung Dysfunction Ann. Thorac. Surg., January 1, 1996; 61(1): 76 - 81. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Utley, E. F. Wilde, S. A. Leyland, M. S. Morgan, and H. D. Johnson Intraoperative blood transfusion is a major risk factor for coronary artery bypass grafting in women Ann. Thorac. Surg., September 1, 1995; 60(3): 570 - 575. [Abstract] [PDF]
|
|
|
|
|
|
G. T. Christakis, S. E. Fremes, J.-P. Koch, S. Harwood, S. Juhasz, E. Sharpe, K. A. Deemar, C. Hamilton, E. Chen, V. Rao, et al. Determinants of low systemic vascular resistance during cardiopulmonary bypass Ann. Thorac. Surg., October 1, 1994; 58(4): 1040 - 1049. [Abstract] [PDF]
|
|
|
|
|
|
L. H. Edmunds Jr Surface-bound heparin--Panacea or peril? Ann. Thorac. Surg., August 1, 1994; 58(2): 285 - 286. [PDF]
|
|
|
|
|
|
D. Johnson, D. Thomson, T. Hurst, K. Prasad, T. Wilson, F. Murphy, A. Saxena, and I. Mayers Neutrophil-mediated acute lung injury after extracorporeal perfusion J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1193 - 1202. [Abstract] [Full Text]
|
|
|
|
|
|
J. Butler, G. M. Rocker, and S. Westaby Inflammatory response to cardiopulmonary bypass Ann. Thorac. Surg., February 1, 1993; 55(2): 552 - 559. [Abstract] [PDF]
|
|
|
|
|
|
V. Videm, E. Fosse, T. E. Mollnes, P. Garred, and J. L. Svennevig Time for new concepts about measurement of complement activation by cardiopulmonary bypass? Ann. Thorac. Surg., October 1, 1992; 54(4): 725 - 731. [Abstract] [PDF]
|
|
|
|
|
|
J. Butler, G. L. Chong, MMed(Anaes), R. J. Baigrie, R. Pillai, S. Westaby, and G. M. Rocker Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation Ann. Thorac. Surg., May 1, 1992; 53(5): 833 - 838. [Abstract] [PDF]
|
|
|
|
|
|
M. L. Myers, C. Webb, M. Moffat, D. McIver, and R. D. Maestro Activated neutrophils impair rabbit heart recovery after hypothermic global ischemia Ann. Thorac. Surg., February 1, 1992; 53(2): 247 - 252. [Abstract] [PDF]
|
|
|
|
|
|
T. E. Mollnes, V. Videm, O. Gotze, M. Harboe, and M. Oppermann Formation of C5a during cardiopulmonary bypass: Inhibition by precoating with heparin Ann. Thorac. Surg., July 1, 1991; 52(1): 92 - 97. [Abstract] [PDF]
|
|
|
|
|
|
J. K. Kirklin Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass Ann. Thorac. Surg., April 1, 1991; 51(4): 529 - 531. [PDF]
|
|
|
|
|
|
J. L. Svennevig, V. Videm, E. Fosse, T. E. Mollnes, P. Garred, and with technical assistance from Hans Nielsen Complement activation with bubble and membrane oxygentors in aortocorpnary bypass grafting Ann. Thorac. Surg., September 1, 1990; 50(3): 387 - 391. [Abstract] [PDF]
|
|
|
|
|
|
P. Kesteven Haemostatic changes during cardiopulmonary bypass Perfusion, January 1, 1990; 5(1_suppl): 9 - 19. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
